This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event
In-Person: October 11-13 • Virtual: October 18-20Hyatt Regency • New Brunswick, NJ

Kenny Yu, PharmD, MBA, 340B ACE
Interim Senior Director of Pharmacy at NYU Langone Health

Profile

Kenny Yu, PharmD, MBA, is the Senior Director of Pharmacy Services at NYU Langone Hospitals (NYULH) in New York. He provides executive leadership and coordination for all pharmacy services provided within NYULH to promote standardization and alignment of practices across all pharmacy sites. He has helped to coordinate pharmacy initiatives across the enterprise, including working closely with the pharmacy leaders at four hospital locations, investigational pharmacy, hospital-owned retail pharmacy, hospital-owned specialty pharmacy, stand-alone ED pharmacy, and nine infusion center pharmacies. He has been instrumental in facilitating pharmacy’s pivotal role in the COVID-19 vaccine rollout across the NYU Langone Health System.


Dr. Yu served as the inaugural director of 340B pharmacy services, starting in 2016. He managed both compliance and optimization of the 340B program, where he and his team built the program from the ground. His role evolved to include pharmacy business and analytics, in which he supported pharmacy-related contract negotiations, pharmacy projects/initiatives, and pharmacy-driven analyses. Before assuming the director’s role, Dr. Yu served as the assistant director of pharmacy, ambulatory services, where he had a dual role of managing an infusion center pharmacy and handling all medication management for NYULH in the ambulatory care setting to promote safety and standardization. Before he stepped into pharmacy leadership, he was an oncology pharmacist at the Perlmutter Cancer Center.


Dr. Yu received his PharmD from Rutgers University in New Jersey and his MBA with a concentration in health care from George Washington University in Washington, DC. He became a 340B Apexus Certified Expert (ACE) in 2017.

Agenda Sessions

  • Understanding Covered Entity (CE) 340B Operations and Good Faith Inquiries (GFI's)

    10:50am